エーザイ（4523）　U.S. FDA CONFIRMS SUFFICIENT DATA TO ADVANCE INVESTIGATIONAL BACE INHIBITOR E2609 FOR TREATMENT OF EARLY ALZHEIMER'S DISEASE TO PHASE III 2016/08/09
/-
読み込み中…